Skip to main content

Herpes Zoster Reactivation in a 40-Year-Old with Psoriasis

  • Chapter
  • First Online:
Clinical Cases in Psoriasis

Part of the book series: Clinical Cases in Dermatology ((CLIDADE))

  • 733 Accesses

Abstract

A 40-year-old male with an 8-year history of psoriasis and psoriatic arthritis presented to the clinic after discontinuing his medication following a herpes zoster outbreak 2 months ago. The shingles rash is completely resolved, and he denied residual pain, sensitivity to light touch, itching, or numbness. Before the infection, the patient’s psoriasis was moderately controlled with etanercept. The patient denied experiencing adverse side effects with etanercept. Since stopping the medication, he believed his psoriasis had worsened with new lesions appearing on his face, scalp, and extremities. He was interested in restarting a biologic agent as previous attempts with phototherapy and methotrexate were not beneficial. He was otherwise healthy and did not use other medications. He has a family history of psoriasis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Adelzadeh L, Jourabchi N, Wu JJ. The risk of herpes zoster during biological therapy for psoriasis and other inflammatory conditions. J Eur Acad Dermatol Venereol. 2014;28(7):846–52. doi:10.1111/jdv.12307.

    Article  CAS  PubMed  Google Scholar 

  • Bolognia J, Schaffer JV, Duncan KO, Ko CJ. Dermatology essentials. Oxford: Saunders and Elsevier; 2014.

    Google Scholar 

  • Dreiher J, Kresch FS, Comaneshter D, Cohen AD. Risk of herpes zoster in patients with psoriasis treated with biologic drugs. J Eur Acad Dermatol Venereol. 2012;26(9):1127–32. doi:10.1111/j.1468-3083.2011.04230.x.

    Article  CAS  PubMed  Google Scholar 

  • Harpaz R, Ortega-Sanchez IR, Seward JF, Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR-5):1–30. quiz CE2–4.

    PubMed  Google Scholar 

  • Shalom G, Zisman D, Bitterman H, Harman-Boehm I, Greenberg-Dotan S, Dreiher J, Feldhamer I, et al. Systemic therapy for psoriasis and the risk of herpes zoster: a 500,000 person-year study. JAMA Dermatol. 2015;151(5):533–8. doi:10.1001/jamadermatol.2014.4956.

    Article  PubMed  Google Scholar 

  • Winthrop KL, Baddley JW, Chen L, Liu L, Grijalva CG, Delzell E, Beukelman T, et al. Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster. JAMA. 2013;309(9):887–95. doi:10.1001/jama.2013.1099.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82(11):1341–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jashin J. Wu .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Pun, S., Amin, M., No, D.J., Wu, J.J. (2017). Herpes Zoster Reactivation in a 40-Year-Old with Psoriasis. In: Wu, J. (eds) Clinical Cases in Psoriasis. Clinical Cases in Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-52779-6_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-52779-6_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-52778-9

  • Online ISBN: 978-3-319-52779-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics